{"entity":{"type":"insider","cik":"0001679225","url":"/insider/0001679225","json_url":"/insider/0001679225.json","name":"Cheval Holdings, Ltd.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":85,"n_filings":14,"first":"2018-03-01","last":"2023-10-20","span_basis":"filed_date"},"name_variants":[{"name":"Cheval Holdings, Ltd.","source":"filing","n_filings":14,"first_seen":"2018-03-01","last_seen":"2023-10-20"}],"transactions":[{"id":8519021,"accession":"0001013594-23-000819","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001013594-23-000819","line_url":"/filing/0001013594-23-000819#line-3","is_derivative":false,"issuer_cik":"0001178179","issuer_name":"HUMANIGEN, INC","issuer_ticker":"HGEN","issuer_name_source":null,"issuer_url":"/issuer/0001178179","owner_cik":null,"owner_name":"BLACK HORSE CAPITAL LP; BLACK HORSE CAPITAL MANAGEMENT LLC; Black Horse Capital Master Fund Ltd.; Chappell Dale; Cheval Holdings, Ltd.","owner_url":null,"role":"Director, Officer (Chief Scientific Officer), Ten percent owner","officer_title":"Chief Scientific Officer","security_title":"Common Stock, $0.001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":276210.0,"shares_display":"276,210","price_per_share":0.011,"price_display":"0.01","price_state":"stated","total_value":3038.31,"total_display":"3,038.31","shares_owned_after":8398871.0,"shares_owned_after_display":"8,398,871","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-10-18","filed_date":"2023-10-20","scope":"insider"},{"id":8519017,"accession":"0001013594-23-000819","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001013594-23-000819","line_url":"/filing/0001013594-23-000819#line-2","is_derivative":false,"issuer_cik":"0001178179","issuer_name":"HUMANIGEN, INC","issuer_ticker":"HGEN","issuer_name_source":null,"issuer_url":"/issuer/0001178179","owner_cik":null,"owner_name":"BLACK HORSE CAPITAL LP; BLACK HORSE CAPITAL MANAGEMENT LLC; Black Horse Capital Master Fund Ltd.; Chappell Dale; Cheval Holdings, Ltd.","owner_url":null,"role":"Director, Officer (Chief Scientific Officer), Ten percent owner","officer_title":"Chief Scientific Officer","security_title":"Common Stock, $0.001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":75887.0,"shares_display":"75,887","price_per_share":0.011,"price_display":"0.01","price_state":"stated","total_value":834.757,"total_display":"834.76","shares_owned_after":2307530.0,"shares_owned_after_display":"2,307,530","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-10-18","filed_date":"2023-10-20","scope":"insider"},{"id":8519012,"accession":"0001013594-23-000819","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001013594-23-000819","line_url":"/filing/0001013594-23-000819#line-1","is_derivative":false,"issuer_cik":"0001178179","issuer_name":"HUMANIGEN, INC","issuer_ticker":"HGEN","issuer_name_source":null,"issuer_url":"/issuer/0001178179","owner_cik":null,"owner_name":"BLACK HORSE CAPITAL LP; BLACK HORSE CAPITAL MANAGEMENT LLC; Black Horse Capital Master Fund Ltd.; Chappell Dale; Cheval Holdings, Ltd.","owner_url":null,"role":"Director, Officer (Chief Scientific Officer), Ten percent owner","officer_title":"Chief Scientific Officer","security_title":"Common Stock, $0.001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":34253.0,"shares_display":"34,253","price_per_share":0.011,"price_display":"0.01","price_state":"stated","total_value":376.783,"total_display":"376.78","shares_owned_after":1041536.0,"shares_owned_after_display":"1,041,536","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-10-18","filed_date":"2023-10-20","scope":"insider"},{"id":6953360,"accession":"0001013594-22-000446","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001013594-22-000446","line_url":"/filing/0001013594-22-000446#line-9","is_derivative":false,"issuer_cik":"0001178179","issuer_name":"HUMANIGEN, INC","issuer_ticker":"HGEN","issuer_name_source":null,"issuer_url":"/issuer/0001178179","owner_cik":null,"owner_name":"BLACK HORSE CAPITAL LP; BLACK HORSE CAPITAL MANAGEMENT LLC; Black Horse Capital Master Fund Ltd.; Chappell Dale; Cheval Holdings, Ltd.","owner_url":null,"role":"Director, Officer (Chief Scientific Officer), Ten percent owner","officer_title":"Chief Scientific Officer","security_title":"Common Stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":381841.0,"shares_display":"381,841","price_per_share":2.228,"price_display":"2.23","price_state":"stated","total_value":850741.748,"total_display":"850,741.75","shares_owned_after":8675081.0,"shares_owned_after_display":"8,675,081","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-05-20","filed_date":"2022-05-20","scope":"insider"},{"id":6953357,"accession":"0001013594-22-000446","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001013594-22-000446","line_url":"/filing/0001013594-22-000446#line-8","is_derivative":false,"issuer_cik":"0001178179","issuer_name":"HUMANIGEN, INC","issuer_ticker":"HGEN","issuer_name_source":null,"issuer_url":"/issuer/0001178179","owner_cik":null,"owner_name":"BLACK HORSE CAPITAL LP; BLACK HORSE CAPITAL MANAGEMENT LLC; Black Horse Capital Master Fund Ltd.; Chappell Dale; Cheval Holdings, Ltd.","owner_url":null,"role":"Director, Officer (Chief Scientific Officer), Ten percent owner","officer_title":"Chief Scientific Officer","security_title":"Common Stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":109098.0,"shares_display":"109,098","price_per_share":2.228,"price_display":"2.23","price_state":"stated","total_value":243070.344,"total_display":"243,070.34","shares_owned_after":2383417.0,"shares_owned_after_display":"2,383,417","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-05-20","filed_date":"2022-05-20","scope":"insider"},{"id":6953354,"accession":"0001013594-22-000446","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001013594-22-000446","line_url":"/filing/0001013594-22-000446#line-7","is_derivative":false,"issuer_cik":"0001178179","issuer_name":"HUMANIGEN, INC","issuer_ticker":"HGEN","issuer_name_source":null,"issuer_url":"/issuer/0001178179","owner_cik":null,"owner_name":"BLACK HORSE CAPITAL LP; BLACK HORSE CAPITAL MANAGEMENT LLC; Black Horse Capital Master Fund Ltd.; Chappell Dale; Cheval Holdings, Ltd.","owner_url":null,"role":"Director, Officer (Chief Scientific Officer), Ten percent owner","officer_title":"Chief Scientific Officer","security_title":"Common Stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":54549.0,"shares_display":"54,549","price_per_share":2.228,"price_display":"2.23","price_state":"stated","total_value":121535.172,"total_display":"121,535.17","shares_owned_after":1075789.0,"shares_owned_after_display":"1,075,789","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-05-20","filed_date":"2022-05-20","scope":"insider"},{"id":6953351,"accession":"0001013594-22-000446","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001013594-22-000446","line_url":"/filing/0001013594-22-000446#line-6","is_derivative":false,"issuer_cik":"0001178179","issuer_name":"HUMANIGEN, INC","issuer_ticker":"HGEN","issuer_name_source":null,"issuer_url":"/issuer/0001178179","owner_cik":null,"owner_name":"BLACK HORSE CAPITAL LP; BLACK HORSE CAPITAL MANAGEMENT LLC; Black Horse Capital Master Fund Ltd.; Chappell Dale; Cheval Holdings, Ltd.","owner_url":null,"role":"Director, Officer (Chief Scientific Officer), Ten percent owner","officer_title":"Chief Scientific Officer","security_title":"Common Stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":226665.0,"shares_display":"226,665","price_per_share":2.186,"price_display":"2.19","price_state":"stated","total_value":495489.69,"total_display":"495,489.69","shares_owned_after":8293240.0,"shares_owned_after_display":"8,293,240","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-05-19","filed_date":"2022-05-20","scope":"insider"},{"id":6953349,"accession":"0001013594-22-000446","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001013594-22-000446","line_url":"/filing/0001013594-22-000446#line-5","is_derivative":false,"issuer_cik":"0001178179","issuer_name":"HUMANIGEN, INC","issuer_ticker":"HGEN","issuer_name_source":null,"issuer_url":"/issuer/0001178179","owner_cik":null,"owner_name":"BLACK HORSE CAPITAL LP; BLACK HORSE CAPITAL MANAGEMENT LLC; Black Horse Capital Master Fund Ltd.; Chappell Dale; Cheval Holdings, Ltd.","owner_url":null,"role":"Director, Officer (Chief Scientific Officer), Ten percent owner","officer_title":"Chief Scientific Officer","security_title":"Common Stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":64762.0,"shares_display":"64,762","price_per_share":2.186,"price_display":"2.19","price_state":"stated","total_value":141569.732,"total_display":"141,569.73","shares_owned_after":2274319.0,"shares_owned_after_display":"2,274,319","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-05-19","filed_date":"2022-05-20","scope":"insider"},{"id":6953347,"accession":"0001013594-22-000446","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001013594-22-000446","line_url":"/filing/0001013594-22-000446#line-4","is_derivative":false,"issuer_cik":"0001178179","issuer_name":"HUMANIGEN, INC","issuer_ticker":"HGEN","issuer_name_source":null,"issuer_url":"/issuer/0001178179","owner_cik":null,"owner_name":"BLACK HORSE CAPITAL LP; BLACK HORSE CAPITAL MANAGEMENT LLC; Black Horse Capital Master Fund Ltd.; Chappell Dale; Cheval Holdings, Ltd.","owner_url":null,"role":"Director, Officer (Chief Scientific Officer), Ten percent owner","officer_title":"Chief Scientific Officer","security_title":"Common Stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":32381.0,"shares_display":"32,381","price_per_share":2.186,"price_display":"2.19","price_state":"stated","total_value":70784.866,"total_display":"70,784.87","shares_owned_after":1021240.0,"shares_owned_after_display":"1,021,240","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-05-19","filed_date":"2022-05-20","scope":"insider"},{"id":6953344,"accession":"0001013594-22-000446","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001013594-22-000446","line_url":"/filing/0001013594-22-000446#line-3","is_derivative":false,"issuer_cik":"0001178179","issuer_name":"HUMANIGEN, INC","issuer_ticker":"HGEN","issuer_name_source":null,"issuer_url":"/issuer/0001178179","owner_cik":null,"owner_name":"BLACK HORSE CAPITAL LP; BLACK HORSE CAPITAL MANAGEMENT LLC; Black Horse Capital Master Fund Ltd.; Chappell Dale; Cheval Holdings, Ltd.","owner_url":null,"role":"Director, Officer (Chief Scientific Officer), Ten percent owner","officer_title":"Chief Scientific Officer","security_title":"Common Stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":121590.0,"shares_display":"121,590","price_per_share":1.962,"price_display":"1.96","price_state":"stated","total_value":238559.58,"total_display":"238,559.58","shares_owned_after":8066575.0,"shares_owned_after_display":"8,066,575","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-05-18","filed_date":"2022-05-20","scope":"insider"},{"id":6953341,"accession":"0001013594-22-000446","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001013594-22-000446","line_url":"/filing/0001013594-22-000446#line-2","is_derivative":false,"issuer_cik":"0001178179","issuer_name":"HUMANIGEN, INC","issuer_ticker":"HGEN","issuer_name_source":null,"issuer_url":"/issuer/0001178179","owner_cik":null,"owner_name":"BLACK HORSE CAPITAL LP; BLACK HORSE CAPITAL MANAGEMENT LLC; Black Horse Capital Master Fund Ltd.; Chappell Dale; Cheval Holdings, Ltd.","owner_url":null,"role":"Director, Officer (Chief Scientific Officer), Ten percent owner","officer_title":"Chief Scientific Officer","security_title":"Common Stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":34740.0,"shares_display":"34,740","price_per_share":1.962,"price_display":"1.96","price_state":"stated","total_value":68159.88,"total_display":"68,159.88","shares_owned_after":2209557.0,"shares_owned_after_display":"2,209,557","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-05-18","filed_date":"2022-05-20","scope":"insider"},{"id":6953337,"accession":"0001013594-22-000446","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001013594-22-000446","line_url":"/filing/0001013594-22-000446#line-1","is_derivative":false,"issuer_cik":"0001178179","issuer_name":"HUMANIGEN, INC","issuer_ticker":"HGEN","issuer_name_source":null,"issuer_url":"/issuer/0001178179","owner_cik":null,"owner_name":"BLACK HORSE CAPITAL LP; BLACK HORSE CAPITAL MANAGEMENT LLC; Black Horse Capital Master Fund Ltd.; Chappell Dale; Cheval Holdings, Ltd.","owner_url":null,"role":"Director, Officer (Chief Scientific Officer), Ten percent owner","officer_title":"Chief Scientific Officer","security_title":"Common Stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":17370.0,"shares_display":"17,370","price_per_share":1.962,"price_display":"1.96","price_state":"stated","total_value":34079.94,"total_display":"34,079.94","shares_owned_after":988859.0,"shares_owned_after_display":"988,859","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-05-18","filed_date":"2022-05-20","scope":"insider"},{"id":6715949,"accession":"0001013594-22-000291","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001013594-22-000291","line_url":"/filing/0001013594-22-000291#line-3","is_derivative":false,"issuer_cik":"0001178179","issuer_name":"HUMANIGEN, INC","issuer_ticker":"HGEN","issuer_name_source":null,"issuer_url":"/issuer/0001178179","owner_cik":null,"owner_name":"BLACK HORSE CAPITAL LP; BLACK HORSE CAPITAL MANAGEMENT LLC; Black Horse Capital Master Fund Ltd.; Chappell Dale; Cheval Holdings, Ltd.","owner_url":null,"role":"Director, Officer (Chief Scientific Officer), Ten percent owner","officer_title":"Chief Scientific Officer","security_title":"Common Stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":700000.0,"shares_display":"700,000","price_per_share":3.0,"price_display":"3.00","price_state":"stated","total_value":2100000.0,"total_display":"2,100,000.00","shares_owned_after":7944985.0,"shares_owned_after_display":"7,944,985","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-03-11","filed_date":"2022-03-15","scope":"insider"},{"id":6715946,"accession":"0001013594-22-000291","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001013594-22-000291","line_url":"/filing/0001013594-22-000291#line-2","is_derivative":false,"issuer_cik":"0001178179","issuer_name":"HUMANIGEN, INC","issuer_ticker":"HGEN","issuer_name_source":null,"issuer_url":"/issuer/0001178179","owner_cik":null,"owner_name":"BLACK HORSE CAPITAL LP; BLACK HORSE CAPITAL MANAGEMENT LLC; Black Horse Capital Master Fund Ltd.; Chappell Dale; Cheval Holdings, Ltd.","owner_url":null,"role":"Director, Officer (Chief Scientific Officer), Ten percent owner","officer_title":"Chief Scientific Officer","security_title":"Common Stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":200000.0,"shares_display":"200,000","price_per_share":3.0,"price_display":"3.00","price_state":"stated","total_value":600000.0,"total_display":"600,000.00","shares_owned_after":2174817.0,"shares_owned_after_display":"2,174,817","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-03-11","filed_date":"2022-03-15","scope":"insider"},{"id":6715943,"accession":"0001013594-22-000291","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001013594-22-000291","line_url":"/filing/0001013594-22-000291#line-1","is_derivative":false,"issuer_cik":"0001178179","issuer_name":"HUMANIGEN, INC","issuer_ticker":"HGEN","issuer_name_source":null,"issuer_url":"/issuer/0001178179","owner_cik":null,"owner_name":"BLACK HORSE CAPITAL LP; BLACK HORSE CAPITAL MANAGEMENT LLC; Black Horse Capital Master Fund Ltd.; Chappell Dale; Cheval Holdings, Ltd.","owner_url":null,"role":"Director, Officer (Chief Scientific Officer), Ten percent owner","officer_title":"Chief Scientific Officer","security_title":"Common Stock, $0.001 par value","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":100000.0,"shares_display":"100,000","price_per_share":3.0,"price_display":"3.00","price_state":"stated","total_value":300000.0,"total_display":"300,000.00","shares_owned_after":971489.0,"shares_owned_after_display":"971,489","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-03-11","filed_date":"2022-03-15","scope":"insider"},{"id":5528177,"accession":"0001013594-21-000672","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001013594-21-000672","line_url":"/filing/0001013594-21-000672#line-6","is_derivative":false,"issuer_cik":"0001178179","issuer_name":"HUMANIGEN, INC","issuer_ticker":"HGEN","issuer_name_source":null,"issuer_url":"/issuer/0001178179","owner_cik":null,"owner_name":"BLACK HORSE CAPITAL LP; BLACK HORSE CAPITAL MANAGEMENT LLC; Black Horse Capital Master Fund Ltd.; Chappell Dale; Cheval Holdings, Ltd.","owner_url":null,"role":"Director, Officer (Chief Scientific Officer), Ten percent owner","officer_title":"Chief Scientific Officer","security_title":"Common Stock, $0.001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":41725.0,"shares_display":"41,725","price_per_share":17.1598,"price_display":"17.16","price_state":"stated","total_value":715992.655,"total_display":"715,992.66","shares_owned_after":7266296.0,"shares_owned_after_display":"7,266,296","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-08-12","filed_date":"2021-08-13","scope":"insider"},{"id":5528173,"accession":"0001013594-21-000672","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001013594-21-000672","line_url":"/filing/0001013594-21-000672#line-5","is_derivative":false,"issuer_cik":"0001178179","issuer_name":"HUMANIGEN, INC","issuer_ticker":"HGEN","issuer_name_source":null,"issuer_url":"/issuer/0001178179","owner_cik":null,"owner_name":"BLACK HORSE CAPITAL LP; BLACK HORSE CAPITAL MANAGEMENT LLC; Black Horse Capital Master Fund Ltd.; Chappell Dale; Cheval Holdings, Ltd.","owner_url":null,"role":"Director, Officer (Chief Scientific Officer), Ten percent owner","officer_title":"Chief Scientific Officer","security_title":"Common Stock, $0.001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11510.0,"shares_display":"11,510","price_per_share":17.1598,"price_display":"17.16","price_state":"stated","total_value":197509.298,"total_display":"197,509.30","shares_owned_after":1980696.0,"shares_owned_after_display":"1,980,696","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-08-12","filed_date":"2021-08-13","scope":"insider"},{"id":5528170,"accession":"0001013594-21-000672","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001013594-21-000672","line_url":"/filing/0001013594-21-000672#line-4","is_derivative":false,"issuer_cik":"0001178179","issuer_name":"HUMANIGEN, INC","issuer_ticker":"HGEN","issuer_name_source":null,"issuer_url":"/issuer/0001178179","owner_cik":null,"owner_name":"BLACK HORSE CAPITAL LP; BLACK HORSE CAPITAL MANAGEMENT LLC; Black Horse Capital Master Fund Ltd.; Chappell Dale; Cheval Holdings, Ltd.","owner_url":null,"role":"Director, Officer (Chief Scientific Officer), Ten percent owner","officer_title":"Chief Scientific Officer","security_title":"Common Stock, $0.001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4316.0,"shares_display":"4,316","price_per_share":17.1598,"price_display":"17.16","price_state":"stated","total_value":74061.6968,"total_display":"74,061.70","shares_owned_after":873693.0,"shares_owned_after_display":"873,693","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-08-12","filed_date":"2021-08-13","scope":"insider"},{"id":5528167,"accession":"0001013594-21-000672","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001013594-21-000672","line_url":"/filing/0001013594-21-000672#line-3","is_derivative":false,"issuer_cik":"0001178179","issuer_name":"HUMANIGEN, INC","issuer_ticker":"HGEN","issuer_name_source":null,"issuer_url":"/issuer/0001178179","owner_cik":null,"owner_name":"BLACK HORSE CAPITAL LP; BLACK HORSE CAPITAL MANAGEMENT LLC; Black Horse Capital Master Fund Ltd.; Chappell Dale; Cheval Holdings, Ltd.","owner_url":null,"role":"Director, Officer (Chief Scientific Officer), Ten percent owner","officer_title":"Chief Scientific Officer","security_title":"Common Stock, $0.001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":79494.0,"shares_display":"79,494","price_per_share":17.0743,"price_display":"17.07","price_state":"stated","total_value":1357304.4042,"total_display":"1,357,304.40","shares_owned_after":7308021.0,"shares_owned_after_display":"7,308,021","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-08-11","filed_date":"2021-08-13","scope":"insider"},{"id":5528161,"accession":"0001013594-21-000672","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001013594-21-000672","line_url":"/filing/0001013594-21-000672#line-2","is_derivative":false,"issuer_cik":"0001178179","issuer_name":"HUMANIGEN, INC","issuer_ticker":"HGEN","issuer_name_source":null,"issuer_url":"/issuer/0001178179","owner_cik":null,"owner_name":"BLACK HORSE CAPITAL LP; BLACK HORSE CAPITAL MANAGEMENT LLC; Black Horse Capital Master Fund Ltd.; Chappell Dale; Cheval Holdings, Ltd.","owner_url":null,"role":"Director, Officer (Chief Scientific Officer), Ten percent owner","officer_title":"Chief Scientific Officer","security_title":"Common Stock, $0.001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":21929.0,"shares_display":"21,929","price_per_share":17.0743,"price_display":"17.07","price_state":"stated","total_value":374422.3247,"total_display":"374,422.32","shares_owned_after":1992206.0,"shares_owned_after_display":"1,992,206","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-08-11","filed_date":"2021-08-13","scope":"insider"},{"id":5528159,"accession":"0001013594-21-000672","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001013594-21-000672","line_url":"/filing/0001013594-21-000672#line-1","is_derivative":false,"issuer_cik":"0001178179","issuer_name":"HUMANIGEN, INC","issuer_ticker":"HGEN","issuer_name_source":null,"issuer_url":"/issuer/0001178179","owner_cik":null,"owner_name":"BLACK HORSE CAPITAL LP; BLACK HORSE CAPITAL MANAGEMENT LLC; Black Horse Capital Master Fund Ltd.; Chappell Dale; Cheval Holdings, Ltd.","owner_url":null,"role":"Director, Officer (Chief Scientific Officer), Ten percent owner","officer_title":"Chief Scientific Officer","security_title":"Common Stock, $0.001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8224.0,"shares_display":"8,224","price_per_share":17.0743,"price_display":"17.07","price_state":"stated","total_value":140419.0432,"total_display":"140,419.04","shares_owned_after":878009.0,"shares_owned_after_display":"878,009","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-08-11","filed_date":"2021-08-13","scope":"insider"},{"id":5331528,"accession":"0001013594-21-000649","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001013594-21-000649","line_url":"/filing/0001013594-21-000649#line-6","is_derivative":false,"issuer_cik":"0001178179","issuer_name":"HUMANIGEN, INC","issuer_ticker":"HGEN","issuer_name_source":null,"issuer_url":"/issuer/0001178179","owner_cik":null,"owner_name":"BLACK HORSE CAPITAL LP; BLACK HORSE CAPITAL MANAGEMENT LLC; Black Horse Capital Master Fund Ltd.; Chappell Dale; Cheval Holdings, Ltd.","owner_url":null,"role":"Director, Officer (Chief Scientific Officer), Ten percent owner","officer_title":"Chief Scientific Officer","security_title":"Common Stock, $0.001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":21311.0,"shares_display":"21,311","price_per_share":17.0342,"price_display":"17.03","price_state":"stated","total_value":363015.8362,"total_display":"363,015.84","shares_owned_after":7366204.0,"shares_owned_after_display":"7,366,204","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-07-29","filed_date":"2021-07-30","scope":"insider"},{"id":5331524,"accession":"0001013594-21-000649","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001013594-21-000649","line_url":"/filing/0001013594-21-000649#line-5","is_derivative":false,"issuer_cik":"0001178179","issuer_name":"HUMANIGEN, INC","issuer_ticker":"HGEN","issuer_name_source":null,"issuer_url":"/issuer/0001178179","owner_cik":null,"owner_name":"BLACK HORSE CAPITAL LP; BLACK HORSE CAPITAL MANAGEMENT LLC; Black Horse Capital Master Fund Ltd.; Chappell Dale; Cheval Holdings, Ltd.","owner_url":null,"role":"Director, Officer (Chief Scientific Officer), Ten percent owner","officer_title":"Chief Scientific Officer","security_title":"Common Stock, $0.001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5879.0,"shares_display":"5,879","price_per_share":17.0342,"price_display":"17.03","price_state":"stated","total_value":100144.0618,"total_display":"100,144.06","shares_owned_after":2008256.0,"shares_owned_after_display":"2,008,256","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-07-29","filed_date":"2021-07-30","scope":"insider"},{"id":5331519,"accession":"0001013594-21-000649","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001013594-21-000649","line_url":"/filing/0001013594-21-000649#line-4","is_derivative":false,"issuer_cik":"0001178179","issuer_name":"HUMANIGEN, INC","issuer_ticker":"HGEN","issuer_name_source":null,"issuer_url":"/issuer/0001178179","owner_cik":null,"owner_name":"BLACK HORSE CAPITAL LP; BLACK HORSE CAPITAL MANAGEMENT LLC; Black Horse Capital Master Fund Ltd.; Chappell Dale; Cheval Holdings, Ltd.","owner_url":null,"role":"Director, Officer (Chief Scientific Officer), Ten percent owner","officer_title":"Chief Scientific Officer","security_title":"Common Stock, $0.001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2204.0,"shares_display":"2,204","price_per_share":17.0342,"price_display":"17.03","price_state":"stated","total_value":37543.3768,"total_display":"37,543.38","shares_owned_after":884029.0,"shares_owned_after_display":"884,029","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-07-29","filed_date":"2021-07-30","scope":"insider"},{"id":5331516,"accession":"0001013594-21-000649","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001013594-21-000649","line_url":"/filing/0001013594-21-000649#line-3","is_derivative":false,"issuer_cik":"0001178179","issuer_name":"HUMANIGEN, INC","issuer_ticker":"HGEN","issuer_name_source":null,"issuer_url":"/issuer/0001178179","owner_cik":null,"owner_name":"BLACK HORSE CAPITAL LP; BLACK HORSE CAPITAL MANAGEMENT LLC; Black Horse Capital Master Fund Ltd.; Chappell Dale; Cheval Holdings, Ltd.","owner_url":null,"role":"Director, Officer (Chief Scientific Officer), Ten percent owner","officer_title":"Chief Scientific Officer","security_title":"Common Stock, $0.001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7027.0,"shares_display":"7,027","price_per_share":17.0411,"price_display":"17.04","price_state":"stated","total_value":119747.8097,"total_display":"119,747.81","shares_owned_after":7387515.0,"shares_owned_after_display":"7,387,515","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-07-28","filed_date":"2021-07-30","scope":"insider"},{"id":5331514,"accession":"0001013594-21-000649","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001013594-21-000649","line_url":"/filing/0001013594-21-000649#line-2","is_derivative":false,"issuer_cik":"0001178179","issuer_name":"HUMANIGEN, INC","issuer_ticker":"HGEN","issuer_name_source":null,"issuer_url":"/issuer/0001178179","owner_cik":null,"owner_name":"BLACK HORSE CAPITAL LP; BLACK HORSE CAPITAL MANAGEMENT LLC; Black Horse Capital Master Fund Ltd.; Chappell Dale; Cheval Holdings, Ltd.","owner_url":null,"role":"Director, Officer (Chief Scientific Officer), Ten percent owner","officer_title":"Chief Scientific Officer","security_title":"Common Stock, $0.001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1938.0,"shares_display":"1,938","price_per_share":17.0411,"price_display":"17.04","price_state":"stated","total_value":33025.6518,"total_display":"33,025.65","shares_owned_after":2014135.0,"shares_owned_after_display":"2,014,135","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-07-28","filed_date":"2021-07-30","scope":"insider"},{"id":5331510,"accession":"0001013594-21-000649","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001013594-21-000649","line_url":"/filing/0001013594-21-000649#line-1","is_derivative":false,"issuer_cik":"0001178179","issuer_name":"HUMANIGEN, INC","issuer_ticker":"HGEN","issuer_name_source":null,"issuer_url":"/issuer/0001178179","owner_cik":null,"owner_name":"BLACK HORSE CAPITAL LP; BLACK HORSE CAPITAL MANAGEMENT LLC; Black Horse Capital Master Fund Ltd.; Chappell Dale; Cheval Holdings, Ltd.","owner_url":null,"role":"Director, Officer (Chief Scientific Officer), Ten percent owner","officer_title":"Chief Scientific Officer","security_title":"Common Stock, $0.001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":727.0,"shares_display":"727","price_per_share":17.0411,"price_display":"17.04","price_state":"stated","total_value":12388.8797,"total_display":"12,388.88","shares_owned_after":886233.0,"shares_owned_after_display":"886,233","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-07-28","filed_date":"2021-07-30","scope":"insider"},{"id":4933231,"accession":"0001013594-21-000633","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001013594-21-000633","line_url":"/filing/0001013594-21-000633#line-9","is_derivative":false,"issuer_cik":"0001178179","issuer_name":"HUMANIGEN, INC","issuer_ticker":"HGEN","issuer_name_source":null,"issuer_url":"/issuer/0001178179","owner_cik":null,"owner_name":"BLACK HORSE CAPITAL LP; BLACK HORSE CAPITAL MANAGEMENT LLC; Black Horse Capital Master Fund Ltd.; Chappell Dale; Cheval Holdings, Ltd.","owner_url":null,"role":"Director, Officer (Chief Scientific Officer), Ten percent owner","officer_title":"Chief Scientific Officer","security_title":"Common Stock, $0.001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4048.0,"shares_display":"4,048","price_per_share":17.0406,"price_display":"17.04","price_state":"stated","total_value":68980.3488,"total_display":"68,980.35","shares_owned_after":7394542.0,"shares_owned_after_display":"7,394,542","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-07-23","filed_date":"2021-07-23","scope":"insider"},{"id":4933227,"accession":"0001013594-21-000633","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001013594-21-000633","line_url":"/filing/0001013594-21-000633#line-8","is_derivative":false,"issuer_cik":"0001178179","issuer_name":"HUMANIGEN, INC","issuer_ticker":"HGEN","issuer_name_source":null,"issuer_url":"/issuer/0001178179","owner_cik":null,"owner_name":"BLACK HORSE CAPITAL LP; BLACK HORSE CAPITAL MANAGEMENT LLC; Black Horse Capital Master Fund Ltd.; Chappell Dale; Cheval Holdings, Ltd.","owner_url":null,"role":"Director, Officer (Chief Scientific Officer), Ten percent owner","officer_title":"Chief Scientific Officer","security_title":"Common Stock, $0.001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1117.0,"shares_display":"1,117","price_per_share":17.0406,"price_display":"17.04","price_state":"stated","total_value":19034.3502,"total_display":"19,034.35","shares_owned_after":2016073.0,"shares_owned_after_display":"2,016,073","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-07-23","filed_date":"2021-07-23","scope":"insider"},{"id":4933222,"accession":"0001013594-21-000633","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001013594-21-000633","line_url":"/filing/0001013594-21-000633#line-7","is_derivative":false,"issuer_cik":"0001178179","issuer_name":"HUMANIGEN, INC","issuer_ticker":"HGEN","issuer_name_source":null,"issuer_url":"/issuer/0001178179","owner_cik":null,"owner_name":"BLACK HORSE CAPITAL LP; BLACK HORSE CAPITAL MANAGEMENT LLC; Black Horse Capital Master Fund Ltd.; Chappell Dale; Cheval Holdings, Ltd.","owner_url":null,"role":"Director, Officer (Chief Scientific Officer), Ten percent owner","officer_title":"Chief Scientific Officer","security_title":"Common Stock, $0.001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":419.0,"shares_display":"419","price_per_share":17.0406,"price_display":"17.04","price_state":"stated","total_value":7140.0114,"total_display":"7,140.01","shares_owned_after":886960.0,"shares_owned_after_display":"886,960","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-07-23","filed_date":"2021-07-23","scope":"insider"},{"id":4933218,"accession":"0001013594-21-000633","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001013594-21-000633","line_url":"/filing/0001013594-21-000633#line-6","is_derivative":false,"issuer_cik":"0001178179","issuer_name":"HUMANIGEN, INC","issuer_ticker":"HGEN","issuer_name_source":null,"issuer_url":"/issuer/0001178179","owner_cik":null,"owner_name":"BLACK HORSE CAPITAL LP; BLACK HORSE CAPITAL MANAGEMENT LLC; Black Horse Capital Master Fund Ltd.; Chappell Dale; Cheval Holdings, Ltd.","owner_url":null,"role":"Director, Officer (Chief Scientific Officer), Ten percent owner","officer_title":"Chief Scientific Officer","security_title":"Common Stock, $0.001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":129054.0,"shares_display":"129,054","price_per_share":17.0377,"price_display":"17.04","price_state":"stated","total_value":2198783.3358,"total_display":"2,198,783.34","shares_owned_after":7398590.0,"shares_owned_after_display":"7,398,590","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-07-22","filed_date":"2021-07-23","scope":"insider"},{"id":4933214,"accession":"0001013594-21-000633","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001013594-21-000633","line_url":"/filing/0001013594-21-000633#line-5","is_derivative":false,"issuer_cik":"0001178179","issuer_name":"HUMANIGEN, INC","issuer_ticker":"HGEN","issuer_name_source":null,"issuer_url":"/issuer/0001178179","owner_cik":null,"owner_name":"BLACK HORSE CAPITAL LP; BLACK HORSE CAPITAL MANAGEMENT LLC; Black Horse Capital Master Fund Ltd.; Chappell Dale; Cheval Holdings, Ltd.","owner_url":null,"role":"Director, Officer (Chief Scientific Officer), Ten percent owner","officer_title":"Chief Scientific Officer","security_title":"Common Stock, $0.001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":35601.0,"shares_display":"35,601","price_per_share":17.0377,"price_display":"17.04","price_state":"stated","total_value":606559.1577,"total_display":"606,559.16","shares_owned_after":2017190.0,"shares_owned_after_display":"2,017,190","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-07-22","filed_date":"2021-07-23","scope":"insider"},{"id":4933209,"accession":"0001013594-21-000633","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001013594-21-000633","line_url":"/filing/0001013594-21-000633#line-4","is_derivative":false,"issuer_cik":"0001178179","issuer_name":"HUMANIGEN, INC","issuer_ticker":"HGEN","issuer_name_source":null,"issuer_url":"/issuer/0001178179","owner_cik":null,"owner_name":"BLACK HORSE CAPITAL LP; BLACK HORSE CAPITAL MANAGEMENT LLC; Black Horse Capital Master Fund Ltd.; Chappell Dale; Cheval Holdings, Ltd.","owner_url":null,"role":"Director, Officer (Chief Scientific Officer), Ten percent owner","officer_title":"Chief Scientific Officer","security_title":"Common Stock, $0.001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13350.0,"shares_display":"13,350","price_per_share":17.0377,"price_display":"17.04","price_state":"stated","total_value":227453.295,"total_display":"227,453.30","shares_owned_after":887379.0,"shares_owned_after_display":"887,379","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-07-22","filed_date":"2021-07-23","scope":"insider"},{"id":4933203,"accession":"0001013594-21-000633","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001013594-21-000633","line_url":"/filing/0001013594-21-000633#line-3","is_derivative":false,"issuer_cik":"0001178179","issuer_name":"HUMANIGEN, INC","issuer_ticker":"HGEN","issuer_name_source":null,"issuer_url":"/issuer/0001178179","owner_cik":null,"owner_name":"BLACK HORSE CAPITAL LP; BLACK HORSE CAPITAL MANAGEMENT LLC; Black Horse Capital Master Fund Ltd.; Chappell Dale; Cheval Holdings, Ltd.","owner_url":null,"role":"Director, Officer (Chief Scientific Officer), Ten percent owner","officer_title":"Chief Scientific Officer","security_title":"Common Stock, $0.001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":96254.0,"shares_display":"96,254","price_per_share":17.1366,"price_display":"17.14","price_state":"stated","total_value":1649466.2964,"total_display":"1,649,466.30","shares_owned_after":7527644.0,"shares_owned_after_display":"7,527,644","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-07-21","filed_date":"2021-07-23","scope":"insider"},{"id":4933196,"accession":"0001013594-21-000633","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001013594-21-000633","line_url":"/filing/0001013594-21-000633#line-2","is_derivative":false,"issuer_cik":"0001178179","issuer_name":"HUMANIGEN, INC","issuer_ticker":"HGEN","issuer_name_source":null,"issuer_url":"/issuer/0001178179","owner_cik":null,"owner_name":"BLACK HORSE CAPITAL LP; BLACK HORSE CAPITAL MANAGEMENT LLC; Black Horse Capital Master Fund Ltd.; Chappell Dale; Cheval Holdings, Ltd.","owner_url":null,"role":"Director, Officer (Chief Scientific Officer), Ten percent owner","officer_title":"Chief Scientific Officer","security_title":"Common Stock, $0.001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":26553.0,"shares_display":"26,553","price_per_share":17.1366,"price_display":"17.14","price_state":"stated","total_value":455028.1398,"total_display":"455,028.14","shares_owned_after":2052791.0,"shares_owned_after_display":"2,052,791","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-07-21","filed_date":"2021-07-23","scope":"insider"},{"id":4933189,"accession":"0001013594-21-000633","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001013594-21-000633","line_url":"/filing/0001013594-21-000633#line-1","is_derivative":false,"issuer_cik":"0001178179","issuer_name":"HUMANIGEN, INC","issuer_ticker":"HGEN","issuer_name_source":null,"issuer_url":"/issuer/0001178179","owner_cik":null,"owner_name":"BLACK HORSE CAPITAL LP; BLACK HORSE CAPITAL MANAGEMENT LLC; Black Horse Capital Master Fund Ltd.; Chappell Dale; Cheval Holdings, Ltd.","owner_url":null,"role":"Director, Officer (Chief Scientific Officer), Ten percent owner","officer_title":"Chief Scientific Officer","security_title":"Common Stock, $0.001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9957.0,"shares_display":"9,957","price_per_share":17.1366,"price_display":"17.14","price_state":"stated","total_value":170629.1262,"total_display":"170,629.13","shares_owned_after":900729.0,"shares_owned_after_display":"900,729","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-07-21","filed_date":"2021-07-23","scope":"insider"},{"id":4208553,"accession":"0001013594-21-000604","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001013594-21-000604","line_url":"/filing/0001013594-21-000604#line-3","is_derivative":false,"issuer_cik":"0001178179","issuer_name":"HUMANIGEN, INC","issuer_ticker":"HGEN","issuer_name_source":null,"issuer_url":"/issuer/0001178179","owner_cik":null,"owner_name":"BLACK HORSE CAPITAL LP; BLACK HORSE CAPITAL MANAGEMENT LLC; Black Horse Capital Master Fund Ltd.; Chappell Dale; Cheval Holdings, Ltd.","owner_url":null,"role":"Director, Officer (Chief Scientific Officer), Ten percent owner","officer_title":"Chief Scientific Officer","security_title":"Common Stock, $0.001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11003.0,"shares_display":"11,003","price_per_share":17.0552,"price_display":"17.06","price_state":"stated","total_value":187658.3656,"total_display":"187,658.37","shares_owned_after":7623898.0,"shares_owned_after_display":"7,623,898","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-07-14","filed_date":"2021-07-16","scope":"insider"},{"id":4208549,"accession":"0001013594-21-000604","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001013594-21-000604","line_url":"/filing/0001013594-21-000604#line-2","is_derivative":false,"issuer_cik":"0001178179","issuer_name":"HUMANIGEN, INC","issuer_ticker":"HGEN","issuer_name_source":null,"issuer_url":"/issuer/0001178179","owner_cik":null,"owner_name":"BLACK HORSE CAPITAL LP; BLACK HORSE CAPITAL MANAGEMENT LLC; Black Horse Capital Master Fund Ltd.; Chappell Dale; Cheval Holdings, Ltd.","owner_url":null,"role":"Director, Officer (Chief Scientific Officer), Ten percent owner","officer_title":"Chief Scientific Officer","security_title":"Common Stock, $0.001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3036.0,"shares_display":"3,036","price_per_share":17.0552,"price_display":"17.06","price_state":"stated","total_value":51779.5872,"total_display":"51,779.59","shares_owned_after":2079344.0,"shares_owned_after_display":"2,079,344","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-07-14","filed_date":"2021-07-16","scope":"insider"},{"id":4208545,"accession":"0001013594-21-000604","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001013594-21-000604","line_url":"/filing/0001013594-21-000604#line-1","is_derivative":false,"issuer_cik":"0001178179","issuer_name":"HUMANIGEN, INC","issuer_ticker":"HGEN","issuer_name_source":null,"issuer_url":"/issuer/0001178179","owner_cik":null,"owner_name":"BLACK HORSE CAPITAL LP; BLACK HORSE CAPITAL MANAGEMENT LLC; Black Horse Capital Master Fund Ltd.; Chappell Dale; Cheval Holdings, Ltd.","owner_url":null,"role":"Director, Officer (Chief Scientific Officer), Ten percent owner","officer_title":"Chief Scientific Officer","security_title":"Common Stock, $0.001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1138.0,"shares_display":"1,138","price_per_share":17.0552,"price_display":"17.06","price_state":"stated","total_value":19408.8176,"total_display":"19,408.82","shares_owned_after":910686.0,"shares_owned_after_display":"910,686","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-07-14","filed_date":"2021-07-16","scope":"insider"},{"id":5528157,"accession":"0001013594-21-000584","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001013594-21-000584","line_url":"/filing/0001013594-21-000584#line-6","is_derivative":false,"issuer_cik":"0001178179","issuer_name":"HUMANIGEN, INC","issuer_ticker":"HGEN","issuer_name_source":null,"issuer_url":"/issuer/0001178179","owner_cik":null,"owner_name":"BLACK HORSE CAPITAL LP; BLACK HORSE CAPITAL MANAGEMENT LLC; Black Horse Capital Master Fund Ltd.; Chappell Dale; Cheval Holdings, Ltd.","owner_url":null,"role":"Director, Officer (Chief Scientific Officer), Ten percent owner","officer_title":"Chief Scientific Officer","security_title":"Common Stock, $0.001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":214626.0,"shares_display":"214,626","price_per_share":17.3721,"price_display":"17.37","price_state":"stated","total_value":3728504.3346,"total_display":"3,728,504.33","shares_owned_after":7634901.0,"shares_owned_after_display":"7,634,901","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-07-09","filed_date":"2021-07-09","scope":"insider"},{"id":5528154,"accession":"0001013594-21-000584","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001013594-21-000584","line_url":"/filing/0001013594-21-000584#line-5","is_derivative":false,"issuer_cik":"0001178179","issuer_name":"HUMANIGEN, INC","issuer_ticker":"HGEN","issuer_name_source":null,"issuer_url":"/issuer/0001178179","owner_cik":null,"owner_name":"BLACK HORSE CAPITAL LP; BLACK HORSE CAPITAL MANAGEMENT LLC; Black Horse Capital Master Fund Ltd.; Chappell Dale; Cheval Holdings, Ltd.","owner_url":null,"role":"Director, Officer (Chief Scientific Officer), Ten percent owner","officer_title":"Chief Scientific Officer","security_title":"Common Stock, $0.001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":59207.0,"shares_display":"59,207","price_per_share":17.3721,"price_display":"17.37","price_state":"stated","total_value":1028549.9247,"total_display":"1,028,549.92","shares_owned_after":2082380.0,"shares_owned_after_display":"2,082,380","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-07-09","filed_date":"2021-07-09","scope":"insider"},{"id":5528152,"accession":"0001013594-21-000584","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001013594-21-000584","line_url":"/filing/0001013594-21-000584#line-4","is_derivative":false,"issuer_cik":"0001178179","issuer_name":"HUMANIGEN, INC","issuer_ticker":"HGEN","issuer_name_source":null,"issuer_url":"/issuer/0001178179","owner_cik":null,"owner_name":"BLACK HORSE CAPITAL LP; BLACK HORSE CAPITAL MANAGEMENT LLC; Black Horse Capital Master Fund Ltd.; Chappell Dale; Cheval Holdings, Ltd.","owner_url":null,"role":"Director, Officer (Chief Scientific Officer), Ten percent owner","officer_title":"Chief Scientific Officer","security_title":"Common Stock, $0.001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":22203.0,"shares_display":"22,203","price_per_share":17.3721,"price_display":"17.37","price_state":"stated","total_value":385712.7363,"total_display":"385,712.74","shares_owned_after":911824.0,"shares_owned_after_display":"911,824","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-07-09","filed_date":"2021-07-09","scope":"insider"},{"id":5528150,"accession":"0001013594-21-000584","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001013594-21-000584","line_url":"/filing/0001013594-21-000584#line-3","is_derivative":false,"issuer_cik":"0001178179","issuer_name":"HUMANIGEN, INC","issuer_ticker":"HGEN","issuer_name_source":null,"issuer_url":"/issuer/0001178179","owner_cik":null,"owner_name":"BLACK HORSE CAPITAL LP; BLACK HORSE CAPITAL MANAGEMENT LLC; Black Horse Capital Master Fund Ltd.; Chappell Dale; Cheval Holdings, Ltd.","owner_url":null,"role":"Director, Officer (Chief Scientific Officer), Ten percent owner","officer_title":"Chief Scientific Officer","security_title":"Common Stock, $0.001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":34807.0,"shares_display":"34,807","price_per_share":17.1654,"price_display":"17.17","price_state":"stated","total_value":597476.0778,"total_display":"597,476.08","shares_owned_after":7849527.0,"shares_owned_after_display":"7,849,527","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-07-08","filed_date":"2021-07-09","scope":"insider"},{"id":5528147,"accession":"0001013594-21-000584","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001013594-21-000584","line_url":"/filing/0001013594-21-000584#line-2","is_derivative":false,"issuer_cik":"0001178179","issuer_name":"HUMANIGEN, INC","issuer_ticker":"HGEN","issuer_name_source":null,"issuer_url":"/issuer/0001178179","owner_cik":null,"owner_name":"BLACK HORSE CAPITAL LP; BLACK HORSE CAPITAL MANAGEMENT LLC; Black Horse Capital Master Fund Ltd.; Chappell Dale; Cheval Holdings, Ltd.","owner_url":null,"role":"Director, Officer (Chief Scientific Officer), Ten percent owner","officer_title":"Chief Scientific Officer","security_title":"Common Stock, $0.001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9602.0,"shares_display":"9,602","price_per_share":17.1654,"price_display":"17.17","price_state":"stated","total_value":164822.1708,"total_display":"164,822.17","shares_owned_after":2141587.0,"shares_owned_after_display":"2,141,587","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-07-08","filed_date":"2021-07-09","scope":"insider"},{"id":5528145,"accession":"0001013594-21-000584","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001013594-21-000584","line_url":"/filing/0001013594-21-000584#line-1","is_derivative":false,"issuer_cik":"0001178179","issuer_name":"HUMANIGEN, INC","issuer_ticker":"HGEN","issuer_name_source":null,"issuer_url":"/issuer/0001178179","owner_cik":null,"owner_name":"BLACK HORSE CAPITAL LP; BLACK HORSE CAPITAL MANAGEMENT LLC; Black Horse Capital Master Fund Ltd.; Chappell Dale; Cheval Holdings, Ltd.","owner_url":null,"role":"Director, Officer (Chief Scientific Officer), Ten percent owner","officer_title":"Chief Scientific Officer","security_title":"Common Stock, $0.001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3601.0,"shares_display":"3,601","price_per_share":17.1654,"price_display":"17.17","price_state":"stated","total_value":61812.6054,"total_display":"61,812.61","shares_owned_after":934027.0,"shares_owned_after_display":"934,027","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-07-08","filed_date":"2021-07-09","scope":"insider"},{"id":4567984,"accession":"0001013594-21-000570","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001013594-21-000570","line_url":"/filing/0001013594-21-000570#line-9","is_derivative":false,"issuer_cik":"0001178179","issuer_name":"HUMANIGEN, INC","issuer_ticker":"HGEN","issuer_name_source":null,"issuer_url":"/issuer/0001178179","owner_cik":null,"owner_name":"BLACK HORSE CAPITAL LP; BLACK HORSE CAPITAL MANAGEMENT LLC; Black Horse Capital Master Fund Ltd.; Chappell Dale; Cheval Holdings, Ltd.","owner_url":null,"role":"Director, Officer (Chief Scientific Officer), Ten percent owner","officer_title":"Chief Scientific Officer","security_title":"Common Stock, $0.001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":74565.0,"shares_display":"74,565","price_per_share":17.12,"price_display":"17.12","price_state":"stated","total_value":1276552.8,"total_display":"1,276,552.80","shares_owned_after":7884334.0,"shares_owned_after_display":"7,884,334","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-07-02","filed_date":"2021-07-02","scope":"insider"},{"id":4567978,"accession":"0001013594-21-000570","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001013594-21-000570","line_url":"/filing/0001013594-21-000570#line-8","is_derivative":false,"issuer_cik":"0001178179","issuer_name":"HUMANIGEN, INC","issuer_ticker":"HGEN","issuer_name_source":null,"issuer_url":"/issuer/0001178179","owner_cik":null,"owner_name":"BLACK HORSE CAPITAL LP; BLACK HORSE CAPITAL MANAGEMENT LLC; Black Horse Capital Master Fund Ltd.; Chappell Dale; Cheval Holdings, Ltd.","owner_url":null,"role":"Director, Officer (Chief Scientific Officer), Ten percent owner","officer_title":"Chief Scientific Officer","security_title":"Common Stock, $0.001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20569.0,"shares_display":"20,569","price_per_share":17.12,"price_display":"17.12","price_state":"stated","total_value":352141.28,"total_display":"352,141.28","shares_owned_after":2151189.0,"shares_owned_after_display":"2,151,189","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-07-02","filed_date":"2021-07-02","scope":"insider"},{"id":4567973,"accession":"0001013594-21-000570","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001013594-21-000570","line_url":"/filing/0001013594-21-000570#line-7","is_derivative":false,"issuer_cik":"0001178179","issuer_name":"HUMANIGEN, INC","issuer_ticker":"HGEN","issuer_name_source":null,"issuer_url":"/issuer/0001178179","owner_cik":null,"owner_name":"BLACK HORSE CAPITAL LP; BLACK HORSE CAPITAL MANAGEMENT LLC; Black Horse Capital Master Fund Ltd.; Chappell Dale; Cheval Holdings, Ltd.","owner_url":null,"role":"Director, Officer (Chief Scientific Officer), Ten percent owner","officer_title":"Chief Scientific Officer","security_title":"Common Stock, $0.001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7714.0,"shares_display":"7,714","price_per_share":17.12,"price_display":"17.12","price_state":"stated","total_value":132063.68,"total_display":"132,063.68","shares_owned_after":937628.0,"shares_owned_after_display":"937,628","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-07-02","filed_date":"2021-07-02","scope":"insider"},{"id":4567970,"accession":"0001013594-21-000570","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001013594-21-000570","line_url":"/filing/0001013594-21-000570#line-6","is_derivative":false,"issuer_cik":"0001178179","issuer_name":"HUMANIGEN, INC","issuer_ticker":"HGEN","issuer_name_source":null,"issuer_url":"/issuer/0001178179","owner_cik":null,"owner_name":"BLACK HORSE CAPITAL LP; BLACK HORSE CAPITAL MANAGEMENT LLC; Black Horse Capital Master Fund Ltd.; Chappell Dale; Cheval Holdings, Ltd.","owner_url":null,"role":"Director, Officer (Chief Scientific Officer), Ten percent owner","officer_title":"Chief Scientific Officer","security_title":"Common Stock, $0.001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":102219.0,"shares_display":"102,219","price_per_share":17.0979,"price_display":"17.10","price_state":"stated","total_value":1747730.2401,"total_display":"1,747,730.24","shares_owned_after":7958899.0,"shares_owned_after_display":"7,958,899","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-07-01","filed_date":"2021-07-02","scope":"insider"},{"id":4567965,"accession":"0001013594-21-000570","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001013594-21-000570","line_url":"/filing/0001013594-21-000570#line-5","is_derivative":false,"issuer_cik":"0001178179","issuer_name":"HUMANIGEN, INC","issuer_ticker":"HGEN","issuer_name_source":null,"issuer_url":"/issuer/0001178179","owner_cik":null,"owner_name":"BLACK HORSE CAPITAL LP; BLACK HORSE CAPITAL MANAGEMENT LLC; Black Horse Capital Master Fund Ltd.; Chappell Dale; Cheval Holdings, Ltd.","owner_url":null,"role":"Director, Officer (Chief Scientific Officer), Ten percent owner","officer_title":"Chief Scientific Officer","security_title":"Common Stock, $0.001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":28198.0,"shares_display":"28,198","price_per_share":17.0979,"price_display":"17.10","price_state":"stated","total_value":482126.5842,"total_display":"482,126.58","shares_owned_after":2171758.0,"shares_owned_after_display":"2,171,758","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-07-01","filed_date":"2021-07-02","scope":"insider"}],"next_cursor":"2021-07-01|4567965","ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001293310","name":"HUMANIGEN, INC","url":"/issuer/0001293310","role":"Ten percent owner","n_filings":14,"first_seen":"2018-03-01","last_seen":"2023-10-20"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001679225","retrieved_at":"2026-08-21T05:11:59+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-19","last_ingest":"2026-08-20T05:22:56.381658+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}